Immuno-oncology in urothelial carcinoma: who or what will ultimately sit on the iron throne?
Ramos JD , Yu EY 
Immunotherapy.2017 Sep ; 9(12):951-954.
PubMedで表示
Google翻訳で開く
(2view , 0users)
- 要約はありません -
PMID: 28971748 [PubMed - in process]
関連論文
- The benefits of immunotherapy combinations.
- Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
- Emerging role of checkpoint inhibition in localized bladder cancer.
- Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.
- [Review] Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.